微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.74% | -76.28% | 196% | 106/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.25% | -87.68% | 66.67% | 111/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.15% | -83.15% | -88.37% | 114/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.29% | -39.72% | -58.65% | 95/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.12% | 28.93% | 53.69% | 93/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.03% | 12.15% | 128.09% | 84/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.89% | 18.67% | -58.41% | 97/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.14% | 65.89% | -11.57% | 97/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.42% | 26.7% | 33.7% | 91/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.81% | 364.1% | 141.33% | 93/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.75% | 327.27% | -41.86% | 101/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.29% | 112.18% | -32.46% | 104/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 1.91% | 170.22% | 389.74% | 108/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.39% | 114.23% | 218.18% | 116/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | -0.33% | 75.19% | 96.88% | 111/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -10.59% | -541.25% | -289.34% | 122/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -2.72% | -160.04% | 0.73% | 103/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -2.74% | -189.84% | -106.02% | 117/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -1.33% | -178.7% | -155.42% | 100/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.4% | -59.32% | -47.02% | 106/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.53% | -20.8% | 48.52% | 72/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.05% | -13.84% | 80.47% | 71/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.69% | -2.31% | -71.36% | 64/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.9% | 26.61% | 3.15% | 79/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.72% | 91.95% | 61.58% | 60/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.54% | 136% | 104.62% | 64/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.73% | 620.83% | -62.88% | 63/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.66% | -75.25% | 56.38% | 88/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.98% | 2% | 98.67% | 79/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.5% | -85.51% | 525% | 87/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.24% | 2% | -98.73% | 81/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 18.83% | -61.29% | 81.93% | 26/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 10.35% | 2% | -78.72% | 12/160 | 3.53% | 南新制药 | 81.7% | 行业排名> |
| 2015-12-31 | 48.64% | -42.2% | -42.2% | 2/160 | 11.35% | 德展健康 | 29.5% | 行业排名> |